Clinical trials in Russia.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Works matching IS 17407745 AND DT 2021 AND VI 18 AND IP 3
Results: 17
1
2
Testing Meldonium: Assessing Soviet pragmatic alternatives to the randomized controlled trial.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 269, doi. 10.1177/17407745211008540
- By:
- Publication type:
- Article
3
Commentary on Chirkova et al.: Some comments on "socialist pharmapolitics".
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 277, doi. 10.1177/17407745211008539
- By:
- Publication type:
- Article
4
Registration of clinical trials in Russia: How does it compare with the World Health Organization International Clinical Trials Registry Platform standards?
- Published in:
- 2021
- By:
- Publication type:
- Letter
5
A Bayesian dose-finding design for outcomes evaluated with uncertainty.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 279, doi. 10.1177/17407745211001521
- By:
- Publication type:
- Article
6
Patient accrual and understanding of informed consent in a two-stage consent design.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 377, doi. 10.1177/1740774520988500
- By:
- Publication type:
- Article
7
Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 324, doi. 10.1177/1740774520988298
- By:
- Publication type:
- Article
8
Randomized controlled trial of an education-based intervention to improve medication adherence: Design considerations in the medication adherence in glaucoma to improve care study.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 343, doi. 10.1177/1740774520988291
- By:
- Publication type:
- Article
9
COVID-19 vaccine trials: The use of active controls and non-inferiority studies.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 335, doi. 10.1177/1740774520988244
- By:
- Publication type:
- Article
10
Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019: A review and meta-analytic approach.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 361, doi. 10.1177/1740774520984870
- By:
- Publication type:
- Article
11
A systematic review of subgroup analyses in randomised clinical trials in cardiovascular disease.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 351, doi. 10.1177/1740774520984866
- By:
- Publication type:
- Article
12
Reopening schools safely in the face of COVID-19: Can cluster randomized trials help?
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 371, doi. 10.1177/1740774520984860
- By:
- Publication type:
- Article
13
Adapting isotonic dose-finding to a dynamic set of drug combinations with application to a phase I leukemia trial.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 314, doi. 10.1177/1740774520983484
- By:
- Publication type:
- Article
14
A modular framework for early-phase seamless oncology trials.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 303, doi. 10.1177/1740774520981939
- By:
- Publication type:
- Article
15
Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 295, doi. 10.1177/1740774520980052
- By:
- Publication type:
- Article
16
Mapping time use in clinical trials for vaccines against emerging infectious diseases.
- Published in:
- Clinical Trials, 2021, v. 18, n. 3, p. 286, doi. 10.1177/1740774520977283
- By:
- Publication type:
- Article
17
Making a distinction between data cleaning and central monitoring in clinical trials.
- Published in:
- 2021
- By:
- Publication type:
- Letter